in ,

On Demand Pharmaceuticals to Further Develop Production Tech Under DoD-HHS Contract

ODP
ODP

The departments of Defense and Health and Human Services have awarded On Demand Pharmaceuticals a $20M contract to develop a “˜pharmacy on demand' system for manufacturing drug product components.

ODP will use the funds to mature its technology as the U.S. government looks to increase domestic production of active pharmaceutical ingredients that are often sourced from overseas suppliers, DoD said Monday.

The department noted that three specific APIs are essential for the treatment of COVID-19 patients and severely ill warfighters in the country.

The company originally developed the API production technology under an agreement with the Defense Advanced Research Projects Agency. DARPA will also oversee work under the new contract.

The effort will use funds from HHS under the Coronavirus Aid, Relief and Economic Security or CARES Act.

ODP's PoD technology is a refrigerator-sized production machine that manufactures APIs and medicines on-demand via synthetic chemical processes.

ExecutiveBiz Logo

Sign Up Now! ExecutiveBiz provides you with Daily Updates and News Briefings about Government Technology

mm

Written by Nichols Martin

a staff writer at Executive Mosaic, produces articles on the federal government's technology and business interests. The coverage of these articles include government contracting, cybersecurity, information technology, health care and national security.

website
Buchanan & Edwards Helps State Dept Build Informational Website for Evacuation Loan Recipients
Mark Lee SVP
ICF to Support NIH Biomedical Library’s IT Operations; Mark Lee Quoted